Cargando…
Challenges to replace ACT as first-line drug
The spread of artemisinin and partner drug resistance through Asia requires changes in first-line therapy. The traditional modus has been the replacement of one first-line anti-malarial regimen with another. The number of anti-malarial drug candidates currently in development may have given false co...
Autores principales: | Phyo, Aung Pyae, von Seidlein, Lorenz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525298/ https://www.ncbi.nlm.nih.gov/pubmed/28738892 http://dx.doi.org/10.1186/s12936-017-1942-5 |
Ejemplares similares
-
Seasonal malaria chemoprevention: successes and missed opportunities
por: Coldiron, Matthew E., et al.
Publicado: (2017) -
Drugs in Development for Malaria
por: Ashley, Elizabeth A., et al.
Publicado: (2018) -
Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021) -
Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020) -
Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)